Patent directory · USPTO A61K / A61P
Patents matching “antibody”
426 pharma patents match "antibody" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 426 pharmaceutical patents matching "antibody" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12319748
Antibody binding to human HER2 and preparation method and use thereof
granted -
US 12319743
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
granted -
US 12319729
Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12311030
Antibody-sting agonist conjugates and their use in immunotherapy
granted -
US 12303724
Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer
granted -
US 12304964
CD38 modulating antibody
granted -
US 12296013
Photosensitizing antibody-fluorophore conjugates
granted -
US 12290505
Tissue factor-targeted antibody-drug conjugate
granted -
US 12291571
Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody
granted -
US 12286479
Treatment with anti-α4β7 antibody
granted -
US 12280124
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof
granted -
US 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted -
US 12263225
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy
granted -
US 12246064
Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate
granted -
US 12240914
Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof
granted -
US 12234294
Pharmaceutical composition of a humanized anti-CD40 antibody
granted -
US 12234295
Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof
granted -
US 12226490
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class
granted -
US 12226524
Coated implants for long-term controlled release of antibody therapeutics
granted -
US 12221460
Antibody drug conjugates
granted -
US 12188005
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
granted -
US 2025002606
Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA
granted -
US 12180277
LILRB4-binding antibody and methods of use thereof
granted -
US 12173078
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
granted